Robotic gastrectomy has emerged as a sophisticated iteration of minimally invasive surgery for gastric cancer, building on the foundations of laparoscopic techniques and open resection. Employing ...
Impact of sarcopenia on short- and long-term outcomes after multimodal therapy for esophageal cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers Symposium. This ...
Does the complication rate after open vs other types of surgery differ in patients undergoing surgery for gastric cancer? In this retrospective Korean study, the authors examined early results after ...
Two new studies presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2024 Annual Scientific Meeting suggest that total robotic metabolic and bariatric surgery may result ...
Prevalence and outcomes of acute kidney injury among hospitalized patients with gastric cancer: Insights from a National Inpatient Sample study (2018-2020). This is an ASCO Meeting Abstract from the ...
Johnson & Johnson MedTech unveiled its long-awaited Ottava surgical robot after winning FDA de novo authorization. It’s the ...
Johnson & Johnson has officially obtained the green light to enter the U.S. robotic surgery market, currently dominated by ...
July 22 (Reuters) - Johnson & Johnson said on Wednesday the U.S. Food and Drug Administration had granted marketing ...
While not disclosing a specific launch timeframe, with de novo clearance in hand, J&J initially plans to launch Ottava with ...